TABLE 2.
Multiplex analytes and associated kits (EMD Millipore Corp.).
| Kit name (#cat) | Abbreviated name | Name |
|---|---|---|
|
TIMP panel 1 (#HTMP1MAG‐54K‐02) |
TIMP‐1 | Tissue inhibitor matrix metalloproteinase‐1 |
| TIMP‐2 | Tissue inhibitor matrix metalloproteinase‐2 | |
|
MMP panel 1 (#HMMP1MAG‐55K‐03) |
MMP‐3 | Matrix metalloproteinase‐3 |
| MMP‐12 | Matrix metalloproteinase‐12 | |
|
MMP panel 2 (#HMMP2MAG‐55K‐04) |
MMP‐1 | Matrix metalloproteinase‐1 |
| MMP‐2 | Matrix metalloproteinase‐2 | |
| MMP‐9 | Matrix metalloproteinase‐9 | |
|
TGF‐β universal kit (#TGFBMAG‐64K‐03) |
TGF‐β1 | Transforming growth factor‐beta 1 |
| TGF‐β2 | Transforming growth factor‐beta 2 | |
|
Human cytokine/chemokine multiplex panel (#HCYTOMAG‐60K‐13) |
Eotaxin | N/A |
| EGF | Endothelial growth factor | |
| GRO | Growth regulated oncogene | |
| IL‐15 | Interleukin‐15 | |
| IL‐1RA | Interleukin‐1 receptor antagonist | |
| IL‐8 | Interleukin‐8 | |
| IP‐10 | Interferon‐gamma‐induced protein‐10 | |
| MCP‐1 | Monocyte chemoattractant protein‐1 | |
| RANTES | Regulated upon activation, normal T cell expressed and presumably secreted chemokine | |
| TNF‐α | Tumor necrosis factor‐alpha | |
| PDGF‐AA | Platelet‐derived growth factor‐aa | |
| PDGF‐AB/BB | Platelet‐derived growth factor‐ab/bb | |
| IL‐6 | Interleukin‐6 | |
| Human Bone Panel (#HBNMAG‐51K‐05) | Leptin | N/A |
| OC | Osteocalcin | |
| SOST | Sclerostin | |
| PTH | Parathyroid hormone | |
| FGF‐23 | Fibroblast growth factor‐23 |